Regulation of MAPK signaling and implications in chronic lymphocytic leukemia

Ashima Shukla, Vipul Shukla, Shantaram S Joshi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy that still remains incurable. Recent studies have highlighted cellular and non-cellular components of the tissue microenvironment in CLL that help nurture the growth of leukemic cells by providing the necessary stimuli for their proliferation and survival. The diverse stimuli in the specialized tissue microenvironment of CLL lead to constitutive activation of several signaling pathways that includes B cell receptor signaling and the associated mitogen-activated protein kinase (MAPK) signaling. Recent findings have described aberrant activation of MAPK signaling and its interactions with other cellular signaling pathways in the pathogenesis of CLL. These studies have shed light on the deregulated molecular mechanisms contributing to hyperactivation of MAPK signaling and provided avenues for therapeutic options for aggressive CLL. In this review, we describe and discuss the current status of our understanding into the role of MAPK signaling in the pathogenesis of CLL.

Original languageEnglish (US)
Pages (from-to)1565-1573
Number of pages9
JournalLeukemia and Lymphoma
Volume59
Issue number7
DOIs
StatePublished - Jul 3 2018

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Mitogen-Activated Protein Kinases
B-Lymphocytes
Growth
Neoplasms

Keywords

  • BCR signaling
  • MAPK signaling
  • Word
  • chronic lymphocytic leukemia

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Regulation of MAPK signaling and implications in chronic lymphocytic leukemia. / Shukla, Ashima; Shukla, Vipul; Joshi, Shantaram S.

In: Leukemia and Lymphoma, Vol. 59, No. 7, 03.07.2018, p. 1565-1573.

Research output: Contribution to journalReview article

@article{b5e7abd0cafe4bd089c8ab8bae00468b,
title = "Regulation of MAPK signaling and implications in chronic lymphocytic leukemia",
abstract = "Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy that still remains incurable. Recent studies have highlighted cellular and non-cellular components of the tissue microenvironment in CLL that help nurture the growth of leukemic cells by providing the necessary stimuli for their proliferation and survival. The diverse stimuli in the specialized tissue microenvironment of CLL lead to constitutive activation of several signaling pathways that includes B cell receptor signaling and the associated mitogen-activated protein kinase (MAPK) signaling. Recent findings have described aberrant activation of MAPK signaling and its interactions with other cellular signaling pathways in the pathogenesis of CLL. These studies have shed light on the deregulated molecular mechanisms contributing to hyperactivation of MAPK signaling and provided avenues for therapeutic options for aggressive CLL. In this review, we describe and discuss the current status of our understanding into the role of MAPK signaling in the pathogenesis of CLL.",
keywords = "BCR signaling, MAPK signaling, Word, chronic lymphocytic leukemia",
author = "Ashima Shukla and Vipul Shukla and Joshi, {Shantaram S}",
year = "2018",
month = "7",
day = "3",
doi = "10.1080/10428194.2017.1370548",
language = "English (US)",
volume = "59",
pages = "1565--1573",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Regulation of MAPK signaling and implications in chronic lymphocytic leukemia

AU - Shukla, Ashima

AU - Shukla, Vipul

AU - Joshi, Shantaram S

PY - 2018/7/3

Y1 - 2018/7/3

N2 - Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy that still remains incurable. Recent studies have highlighted cellular and non-cellular components of the tissue microenvironment in CLL that help nurture the growth of leukemic cells by providing the necessary stimuli for their proliferation and survival. The diverse stimuli in the specialized tissue microenvironment of CLL lead to constitutive activation of several signaling pathways that includes B cell receptor signaling and the associated mitogen-activated protein kinase (MAPK) signaling. Recent findings have described aberrant activation of MAPK signaling and its interactions with other cellular signaling pathways in the pathogenesis of CLL. These studies have shed light on the deregulated molecular mechanisms contributing to hyperactivation of MAPK signaling and provided avenues for therapeutic options for aggressive CLL. In this review, we describe and discuss the current status of our understanding into the role of MAPK signaling in the pathogenesis of CLL.

AB - Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy that still remains incurable. Recent studies have highlighted cellular and non-cellular components of the tissue microenvironment in CLL that help nurture the growth of leukemic cells by providing the necessary stimuli for their proliferation and survival. The diverse stimuli in the specialized tissue microenvironment of CLL lead to constitutive activation of several signaling pathways that includes B cell receptor signaling and the associated mitogen-activated protein kinase (MAPK) signaling. Recent findings have described aberrant activation of MAPK signaling and its interactions with other cellular signaling pathways in the pathogenesis of CLL. These studies have shed light on the deregulated molecular mechanisms contributing to hyperactivation of MAPK signaling and provided avenues for therapeutic options for aggressive CLL. In this review, we describe and discuss the current status of our understanding into the role of MAPK signaling in the pathogenesis of CLL.

KW - BCR signaling

KW - MAPK signaling

KW - Word

KW - chronic lymphocytic leukemia

UR - http://www.scopus.com/inward/record.url?scp=85029447838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029447838&partnerID=8YFLogxK

U2 - 10.1080/10428194.2017.1370548

DO - 10.1080/10428194.2017.1370548

M3 - Review article

C2 - 28882083

AN - SCOPUS:85029447838

VL - 59

SP - 1565

EP - 1573

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 7

ER -